Trials / Completed
CompletedNCT00037050
Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria
Linezolid vs. Vancomycin/Oxacillin/Dicloxacillin in the Treatment of Catheter-Related Gram-Positive Bloodstream Infections
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 739 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 13 Years
- Healthy volunteers
- Not accepted
Summary
This study will treat patients who have a short term central catheter that is thought to be infected with a specific bacteria (gram positive bacteria)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Linezolid | |
| DRUG | Vancomycin | |
| DRUG | Oxacillin | |
| DRUG | Dicloxacillin |
Timeline
- Start date
- 2002-04-01
- Completion
- 2005-07-01
- First posted
- 2002-05-15
- Last updated
- 2009-09-14
Source: ClinicalTrials.gov record NCT00037050. Inclusion in this directory is not an endorsement.